Welcome to LookChem.com Sign In|Join Free

CAS

  • or

733806-87-6

C15H13N3 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

733806-87-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 733806-87-6 Structure

  • Basic information

    1. Product Name: C15H13N3
    2. Synonyms:
    3. CAS NO:733806-87-6
    4. Molecular Formula:
    5. Molecular Weight: 235.288
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 733806-87-6.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C15H13N3(CAS DataBase Reference)
    10. NIST Chemistry Reference: C15H13N3(733806-87-6)
    11. EPA Substance Registry System: C15H13N3(733806-87-6)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 733806-87-6(Hazardous Substances Data)

733806-87-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 733806-87-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,3,3,8,0 and 6 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 733806-87:
(8*7)+(7*3)+(6*3)+(5*8)+(4*0)+(3*6)+(2*8)+(1*7)=176
176 % 10 = 6
So 733806-87-6 is a valid CAS Registry Number.

733806-87-6Downstream Products

733806-87-6Relevant articles and documents

Design of novel quinazoline derivatives and related analogues as potent and selective ALK5 inhibitors

Gellibert,Fouchet,Nguyen,Wang,Krysa,de Gouville,Huet,Dodic

scheme or table, p. 2277 - 2281 (2009/12/07)

Starting from quinazoline 3a, we designed potent and selective ALK5 inhibitors over p38MAP kinase from a rational drug design approach based on co-crystal structures in the human ALK5 kinase domain. The quinazoline 3d exhibited also in vivo activity in an acute rat model of DMN-induced liver fibrosis when administered orally at 5 mg/kg (bid).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 733806-87-6